Evidence map›Paper›PMID 39136713›Full record

ArticleNeuroradiology2024

Assessing the newly proposed MRI criteria for diagnosing sporadic Creutzfeldt-Jakob disease.

Daniel Barber, Nicholas Trost, Christiane Stehmann, Victoria Lewis, James Doecke, Ash Jhamb, Shin-Han Leon Winata, Steven Collins

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Daniel BarberAustralian National CJD Registry The Florey, Austin Health and Western Health, Melbourne, Australia. Daniel.barber@austin.org.au.ORCID http://orcid.org/0000-0001-6825-1437
Nicholas TrostSt Vincent's Hospital, Melbourne, Australia.
Christiane StehmannAustralian National CJD Registry, The Florey and/or Department of Medicine (RMH), The University of Melbourne, Melbourne, Australia.
Victoria LewisAustralian National CJD Registry, The Florey and/or Department of Medicine (RMH), The University of Melbourne, Melbourne, Australia.
James DoeckeAustralian E-Health Research Centre, CSIRO, Canberra, Australia.
Ash JhambSt Vincent's Hospital, Melbourne, Australia.
Shin-Han Leon WinataSt Vincent's Hospital, Melbourne, Australia.
Steven CollinsAustralian National CJD Registry, The Florey and Department of Medicine (RMH), The University of Melbourne, Melbourne, Australia. s.collins@unimelb.edu.au.

Funding

Australian Government Australian Government
6 · The paper itself

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is a frequent differential diagnostic consideration in patients with rapidly progressive dementia (RPD). Fortunately, in the last 2 decades there has been substantial cumulative improvements in sCJD biomarkers, particularly those based on imaging and cerebrospinal fluid (CSF) interrogation. Brain MRI is a very frequently employed investigation in patients with RPD, often utilized quite early in the evaluation and thereby offering a potentially key role in prompting initial concerns for sCJD. Extant conventional MRI criteria for sCJD diagnosis are relatively stringent, requiring fluid attenuated inversion recovery (FLAIR) or diffusion weighted imaging (DWI) high signal changes in 2 or more cortical regions (excluding frontal) or in both the caudate and putamen. Challenging these conventional criteria, a recent publication described improved sensitivity and unchanged specificity if MRI criteria were arguably less rigorous, requiring DWI high signal changes in only 1 or more of 7 discrete brain regions: frontal, parietal, occipital or temporal cortices, as well as the caudate, putamen or thalamus. The aim of the current study was to test the diagnostic performance of this proposed change in MRI criteria in the Australian context and compare it with conventional criteria, as well as 2 other stringent sets of criteria, predicting that a similar improved sensitivity with unchanged specificity would be observed when the proposed criteria were utilized. Sixty-five definite sCJD cases were compared with 63 age- and sex-matched controls. Radiological review of all MRIs applying the different sets of MRI criteria was undertaken by a blinded neuroradiologist, very experienced in CJD interpretation, with independent assessment of 71 MRIs performed by a second blinded neuroradiologist less experienced in sCJD imaging findings. Our study found the sensitivity of the recently proposed MRI criteria (92.3%) to be comparable to that originally reported (90-95%) and also equivalent to the conventional MRI diagnostic criteria (92.3%), while the specificities were also quite similar between the conventional MRI criteria (87.3%) and proposed criteria (85.7%), with the latter lower than previously reported. Negative predictive values and positive predictive values were also very similar between the conventional and proposed MRI criteria. Other MRI criteria assessed were associated with unacceptably low sensitivity for clinical use. Inter-rater reliability as assessed by intra-class correlation coefficients (ICC) revealed moderate reliability for the conventional and proposed MRI criteria, modestly better in the former and when the frontal lobe was retained versus excluded in comparisons.

Indexed as

Creutzfeldt-Jakob SyndromeMagnetic Resonance ImagingSensitivity and SpecificityAgedAged, 80 and overAustraliaDiagnosis, DifferentialFemaleHumansMaleMiddle AgedCreutzfeldt-Jakob diseaseCriteriaDiagnosticMRI

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.